Status:
COMPLETED
Treatment Protocol and Long-Term Outcomes in Craniofacial Fibrous Dysplasia
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Craniofacial Fibrous Dysplasia
Eligibility:
All Genders
Brief Summary
Craniofacial fibrous dysplasia (CFD) is a nonneoplastic disease characterized by fibro-osseous lesions in the affected bones. Treatment is mainly surgical and is stratified based on four different ana...
Detailed Description
According to Chen et. al for the appropriate surgical management of FD the craniofacial skeleton can be divided into four zones according to the consideration of facial cosmesis, vital anatomical regi...
Eligibility Criteria
Inclusion
- Received CFD surgical intervention between 1972 and 2019
- Personal interviews: between late 2019 and 2020, covering a postoperative period of over 20 years
- All the surgery were performed by a senior surgeon (Yu-Ray Chen) at Chang Gung Craniofacial Center
Exclusion
- Patients who underwent surgical treatment at other institutions during the follow-up period or those who did not return to the craniofacial outpatient department for follow-up and receive computed tomography scans between 2019 and 2020 will be excluded.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 14 2021
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT06167122
Start Date
March 1 2020
End Date
March 14 2021
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taoyuan District, Taiwan